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Two hundred (200) strains of S. aureus and P. aeruginosa 
were isolated from clinical samples collected from patients in 
Murtala Muhammad Specialist Hospital and Infectious 
Diseases Hospital, Kano. The confirmed isolates were tested 
for resistance to quinolones by the agar disk diffusion 
susceptibility test and the agar dilution minimum inhibitory 
concentration test. A resistance prevalence rate of 27% and 
38% were seen in S. aureus and P. aeruginosa respectively. 
Eighteen S. aureus isolates were resistant to only one 
quinolone, while 9 had multiple resistances. 25 P. aeruginosa 
isolates were resistant to one quinolone, while 13 had multiple 
resistances. Nine resistance patterns were observed in all the 
isolates with S. aureus isolates having 8 while P. aeruginosa 
had 7. There was no significant difference (p>0.05) in the 
resistances observed in S. aureus and P. aeruginosa isolated 
from the male or female patients except in the case of 2 S. 
aureus isolates that were resistant to sparfloxacin. Quinolones 
could still be relied upon as effective antibiotics in treating S. 
aureus and P. aeruginosa infections. The need to emphasize 
enforcement of antibiotic use policies in developing countries 
is further justified by these findings. 
 




Quinolones have been used to treat both nosocomial and 
community acquired infections. The quinolones act by inhibiting 
topoisomerase II and DNA gyrase in Gram positive and Gram 
negative bacteria respectively, thereby interfering with DNA 
synthesis in the bacteria (Oliphant &  Green, 2002). However, 
resistance to quinolones has been reported in various places 
especially in developing countries. Poverty, inappropriate 
prescribing methods, counterfeit and substandard drugs, poor 
laboratory support and surveillance, lack of antibiotic combination 
strategies or treatment methods and non-adherence to laid down 
drugs policies have been identified as the major causes of 
resistance to antibiotics in the developing countries (Okeke et al., 
1999; Okeke et al., 2005). 
 
 
It is known that drugs found outside hospital set-ups were often 
sold by hawkers and in shops (Hart & Kariuki, 1998; Okeke et al., 
2007). These drugs are usually kept under unsuitable conditions 
for drugs storage and some are sold even after expiration. Another 
factor that has been identified as contributing to spread of antibiotic 
resistance in the developing countries is the use of antibiotics in 
fish and animal production. The drugs are used to boost the 
production and higher yield in meat and other animal products 
(WHO, 1998; WHO, 2002; Okoli et al., 2005). 
 
Staphylococcus aureus and P. aeruginosa have been widely 
incriminated as aetiologic agents causing both community acquired 
and nosocomial infections. In both cases, these organisms are 
often difficult to treat using first line antibiotics and hence require 
broad spectrum antibiotics. Onanuga et al., (2005) tested S. aureus 
isolated from women in Abuja, Nigeria against some antibiotics and 
found 3.3% resistance to sparfloxacin, ciprofloxacin and ofloxacin, 
while 10% resistance was seen in pefloxacin. A similar study by 
Aibinu et al. (2005) in Lagos showed an increased resistance to 
quinolones (22.3%) compared to 2.0% obtained in 1999. 
 
In a study by Daini et al. (2005) at University College Hospital, 
Ibadan high resistance was found to ofloxacin (44.0%), pefloxacin 
(30.1%) and ciprofloxacin (21.7%) from P. aeruginosa isolates 
obtained in the hospital. Olayinka et al., (2004a) tested the 
susceptibility of some S. aureus isolated from Zaria Nigeria to 
some antibiotics and found 4.8% resistance to ciprofloxacin but no 
resistance to ofloxacin. A study of P. aeruginosa isolated from 
urine of students at Ahmadu Bello University, Zaria showed uniform 
susceptibility to ciprofloxacin (Olayinka et al., 2004b). All the S. 
aureus isolates studied in Abia were resistant to nalidixic acid 
(Chigbu & Ezeronye, 2003). 
 
There are no reports on the resistance patterns of S. aureus and P. 
aeruginosa to quinolones in Kano metropolis. In view of the 
significance of Kano as a centre of commerce and densely 
populated city, this work will provide some information on the 
quinolones-resistance patterns of these pathogens to aid planning 
and control purposes.  
 
MATERIALS AND METHODS 
Bacterial isolation and characterization: Clinical samples 
comprising of sputum, urine, wound swab, ear swab, urethral swab, 
and  high vaginal swab obtained from Murtala Muhammad 
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specialist hospital (MMSH) and Infectious Diseases hospital (IDH), 
Kano were cultured on Cetrimide agar and Mannitol salt agar. 
Colonies that were suspected to be S. aureus and P. aeruginosa 
were confirmed using biochemical tests (Cheesbrough, 2002). 
 
Antibiotic Susceptibility Tests. The 200 confirmed isolates (100 
each of S. aureus and P. aeruginosa) were screened for 
susceptibilities to nalidixic acid, ciprofloxacin, ofloxacin, pefloxacin 
and sparfloxacin by the disc diffusion susceptibility test on Mueller 
Hinton agar (NCCLS, 2003). All resistant isolates (in the disc 
diffusion break points) were confirmed by the agar dilution 
minimum inhibitory concentration test (NCCLS, 2004). 
 
RESULTS 
The study showed that 27 of the S. aureus isolates were resistant 
to the quinolones. Eighteen were resistant to only one quinolones 
(i.e. 17 resistant to nalidixic acid and 1 resistant to ciprofloxacin) 
while 9 had multiple-resistances. Thirty eight P. aeruginosa isolates 
were resistant to the quinolones, 25 were resistant to one 




Thirteen had multiple resistances. More resistances were found in 
P. aeruginosa isolates compared to S. aureus isolates especially to 
nalidixic acid, ciprofloxacin and ofloxacin. Sparfloxacin permitted 
the least number of resistant isolates (Fig. 1). 
 
Nine resistance patterns were observed in all. 8 patterns were 
observed in quinolones resistant S. aureus isolates and 7 patterns 
observed in the P. aeruginosa resistant isolates as shown in 
Tables 1 and 2 respectively.  
 
The results show that 54 of the S. aureus isolates were obtained 
from the male patients while 46 were from the female patients. 
There was no statistically significant difference (p>0.05) in the 
resistances of S. aureus isolated from male and female patients to 
nalidixic acid, ciprofloxacin, ofloxacin and pefloxacin (Fig. 2). 
 
In the case of P. aeruginosa isolates, 59 were from the male 
patients while 41 were from the female patients. There were also 
no statistically significant differences in the resistances found in P. 
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FIG. 1. DISTRIBUTION OF THE RESISTANT S. aureus AND P. aeruginosa.  
 
 
TABLE 1. RESISTANCE PATTERNS OF QUINOLONE-RESISTANT S. aureus ISOLATES. 
 
NUMBER OF  
QUINOLONES  
RESISTANT TO 
NUMBER OF S. AUREUS ISOLATES 













3 2 (7.4%) NAL, CIP, PEF 
4 2 (7.4%) 
1 (3.7%) 
NAL, CIP, OFX, PEF 
NAL, CIP, PEF, SPX 
5 1 (3.7%) NAL, CIP, OFX, PEF, SPX. 
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NUMBER OF P. AERUGINOSA 
WITH PATTERN (%) 
 
RESISTANCE PATTERNS 




2 5 (13.2%) NAL, CIP 
3 1 (2.6%) 
1 (2.6%) 
NAL, CIP, PEF 
NAL, OFX, PEF 
4 4 (10.5%) NAL, CIP, OFX, PEF 
5 2 (5.3%) NAL, CIP, OFX, PEF, SPX. 





























FIG. 2. DISTRIBUTION OF QUINOLONES RESISTANT S. aureus ISOLATES  



























FIG. 3. DISTRIBUTION OF QUINOLONES RESISTANT P. aeruginosa ISOLATES 
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An exceptionally high resistance to quinolones was reported by 
Enabulele et al., (2006) in Benin, Edo state. This is not the case in 
the present study. The quinolones were found to be effective 
against both S. aureus and P. aeruginosa isolates tested with few 
resistant cases. More of the P. aeruginosa isolates were resistant 
to multiple quinolones compared to the S. aureus isolates. This is 
not unexpected since P. aeruginosa is a Gram negative bacterium 
coupled with their well known complex cell structure that has been 
reported to enhance their innate resistances to antimicrobial 
agents. In other words, Gram negative bacteria as a group are 
inherently resistant to a number of important antimicrobial agents 
that are very effective against Gram positive organisms. One 
logical reason for this has been found in the differences in 
structural and chemical compositions of the outer layers of the cells 
(Russell & Gould, 1988).  
 
There was a high level of resistance to nalidixic acid by several of 
the isolates in this study. This may be because the antibiotic is now 
cheap and could be afforded by a greater number of people, a 
situation that could encourage abuse and misuse. However, 
nalidixic acid is normally not indicated in P. aeruginosa infections 
(King et al., 2000) and therefore the observed high level resistance 
shown by P. aeuginosa isolates does not pose clinical difficulties. 
 
In Respiratory Tract and Urinary Tract Infections, P. aeruginosa 
grows as aggregates of cells (microcolonies) encased in a 
protective alginate polysaccharide referred to as biofilm thereby 
resisting eradication by physical and biochemical agents (Lambert, 
2002; Hogan & Kolter, 2002). The biofilm formation also assists the 
culprit organism to establish itself and resist drug treatments (Yi et 
al., 2005). This implies that organisms may display clear 
susceptibilities to antibiotics in the in vitro studies and still be 
resistant in vivo especially because P. aeruginosa has other 
resistance mechanisms such as resistance to phagocytosis and to 
the serum bactericidal chemicals due to its mucoid capsule 
(Ochsner et al., 2002) coupled with the fact that most P. 
aeruginosa infections are both invasive and toxinogenic (Iglewski, 
2004). This renders the organism difficult to treat.  
 
Apart from the findings in Benin, high quinolones resistance have 
also been reported in P. aeruginosa isolated from other parts of 
Nigeria (Anupurba et al., 2006; Oguntibeju & Nwobu, 2004), but 
reports on S. aureus resistance profiles have been less alarming 
(Olayinka et al., 2004a; Onanuga et al., 2005) especially in the 
Northern part of Nigeria where the present study is based. 
 
The least resistance in the two groups of isolates used in this study 
were observed in Sparfloxacin. This is contrary to the findings by 
Nwanze et al., (2007) when they studied UTI in Igbinedion 
University Teaching Hospital, Delta State. They reported that 
ofloxacin was the most effective followed by sparfloxacin, 
pefloxacin then ciprofloxacin. Idu & Odjimogho (2003) once 
showed that ciprofloxacin was the most effective quinolone during 
their study. This goes to show that regional differences probably 
play a role in the resistance profiles of bacteria and further justifies 
the need to undertake antibiotic susceptibility studies on bacterial 




There was generally a low level of resistance in both S. aureus and  
P. aeruginosa isolated in this study. However, as it has been noted 
earlier, conditions do exist in Kano which favour the emergence of 
antibiotic resistance in pathogenic organisms. Similar conditions no 
doubt exist in other parts of Nigeria and in Africa as a whole. To 
safeguard the populace therefore, there is a need to enforce 
antibiotic use policies effectively in Nigeria. 
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